Updates June

• Former IPL commissioner Lalit Modi revealed on June 4, 2026, that a biopic based on his life is currently in development. • Modi stated that actor Ranveer Singh has expressed a strong interest in portraying him in the upcoming film. • The project highlights the intersection of sports administration and cinema, focusing on the life of one of cricket's most controversial figures.

• Global stocks retreated from record highs on June 4 after Broadcom Inc. issued a weak forecast, dampening the artificial-intelligence trade. • Broadcom shares tumbled 14% in extended trading, contributing to a 0.5% drop in Nasdaq 100 futures. • Asian markets were hit hard, with MSCI’s index for Asian shares falling 1.6% and South Korea’s Kospi dropping 1.7%, ending a four-day rally.

• A series of international soccer friendlies are scheduled for June 3, featuring teams preparing for the World Cup. • Key matchups include Congo DR against Denmark at 2:00 PM in Belgium, as well as Luxembourg vs. Italy and Netherlands vs. Algeria, both starting at 2:45 PM. • These matches serve as critical preparation for national teams to refine their tactics and rosters ahead of the global tournament.

• Mamata Banerjee and Abhishek Banerjee are scheduled to attend a meeting of the INDIA bloc on June 8th. • The event serves as a critical coordination effort for the opposition alliance to align strategies ahead of upcoming political challenges. • This meeting is significant as it reinforces the unity of the bloc and the active participation of the Trinamool Congress (TMC) leadership.

• The FDA recently approved the oral antiviral drug ensitrelvir (Xocova) for use as post-exposure prophylaxis (PEP). • The medication is designed to be taken within 72 hours after a person has been exposed to someone with COVID-19 to prevent infection. • The Sick Times is calling on the NIH and HHS to conduct further studies on the drug to better understand its efficacy and application.

• During the week of June 19, 2023, the FDA issued several key approvals, including a $3.2 million gene therapy and the first anti-inflammatory drug designed for cardiovascular disease. • Other approved treatments include a subcutaneous version of Vyvgart for myasthenia gravis and the expansion of Jardiance and Synjardy for pediatric patients with type 2 diabetes. • Conversely, the agency rejected three therapies targeting nonalcoholic steatohepatitis (NASH), retinal cancer, and rare fungal infections.

• NASA Science is hosting a PhysPAG Community Webinar on June 2, 2026, from 2:00 PM to 3:00 PM Eastern Time to discuss the ASTRA Initiative. • The initiative focuses on driving science questions and exploring the trade space for various implementation options for new mission concepts. • NASA encourages researchers to collaborate with Special Interest Groups (SIGs) and Standing Advisory Groups (SAGs) to synthesize individual ideas into broader, community-supported mission concepts.